跳至主要内容
临床试验/KCT0001914
KCT0001914招募中未知

Clinical Impact of Breast Parenchyma Enhancement Pattern of Breast MRI in Patients Treated with Breast Conserving Therapy and Chemotherapy

The Catholic University of Korea0 个研究点目标入组 305 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
305

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
20(Year) 至 70(Year)(—)
性别
Female

入选标准

  • 1. 20~ 70 old aged woman (cancer detection time based)
  • 2. histological confirmation of invasive breast cancer
  • 3. margin negative result at the breast conserving surgery
  • 4. underwent breast conserving surgery 6~12 months before
  • 5. underwent mammography, ultrasonography, and breast MRI regularly 6~12

排除标准

  • 1. GFR (glomerular filtration rate) < 30 mL/min/1.73m2, or known chronic renal failure
  • 2. Acute renal insufficiency of any intensity, either due to hepato-renal syndrome or occurring in the perioperative liver transplantation period.
  • 3. Distant metastasis at the time of breast conserving surgery
  • 4. Pregnant or lactating women
  • 5. History of contraindication of contrast enhanced MRI such as claustrophobia, hypersensitivity to intravenous contrast media
  • 6. Contraindications to the use of Gd-containing contrast agents (including subjects who are suspected for or known to have NSF)
  • 7. History of severe allergic or anaphylactoid reaction to any allergen including drugs and contrast agents.
  • 8. Patients unable and/or unwilling to comply with treatment or study instructions.

研究者

相似试验